CompletedPHASE1, PHASE2NCT02354781

Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy

Studying Duchenne muscular dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Jerry R. Mendell
Principal Investigator
Jerry R Mendell, MD
Director, Center for Gene Therapy, Nationwide Children's Hospital
Intervention
rAAV1.CMV.huFollistin344(biological)
Enrollment
3 enrolled
Eligibility
7 years · MALE
Timeline
20152017

Study locations (1)

Collaborators

Duchenne Alliance · Milo Therapeutics

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02354781 on ClinicalTrials.gov

Other trials for Duchenne muscular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Duchenne muscular dystrophy

← Back to all trials